FRANCOLINI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.991
EU - Europa 3.612
AS - Asia 3.476
SA - Sud America 341
AF - Africa 70
OC - Oceania 41
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.895
RU - Federazione Russa 1.398
SG - Singapore 1.014
CN - Cina 973
IT - Italia 824
HK - Hong Kong 500
KR - Corea 297
PL - Polonia 289
BR - Brasile 271
VN - Vietnam 259
IE - Irlanda 244
DE - Germania 182
FR - Francia 182
SE - Svezia 178
FI - Finlandia 102
IN - India 94
GB - Regno Unito 87
JO - Giordania 81
BD - Bangladesh 72
CA - Canada 54
ID - Indonesia 41
AU - Australia 39
AR - Argentina 31
JP - Giappone 30
NL - Olanda 28
IQ - Iraq 25
MX - Messico 20
ES - Italia 19
TR - Turchia 16
ZA - Sudafrica 15
BE - Belgio 13
CH - Svizzera 12
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
NG - Nigeria 10
UA - Ucraina 10
VE - Venezuela 10
LT - Lituania 9
PK - Pakistan 8
SA - Arabia Saudita 8
TN - Tunisia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
MA - Marocco 7
CL - Cile 6
KE - Kenya 6
KZ - Kazakistan 6
PH - Filippine 6
IL - Israele 5
CO - Colombia 4
UY - Uruguay 4
AT - Austria 3
BJ - Benin 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
PE - Perù 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 13.530
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.263
Ashburn 863
Singapore 751
Hong Kong 441
Fairfield 390
Seoul 296
Chandler 291
San Jose 284
Warsaw 280
Hefei 277
Dublin 242
Woodbridge 205
Seattle 195
Houston 158
Cambridge 149
Beijing 142
Wilmington 142
Milan 127
Los Angeles 122
Munich 111
Buffalo 95
Ann Arbor 87
Ho Chi Minh City 83
Dearborn 77
Florence 75
Paris 75
Rome 75
Lauterbourg 67
New York 67
Lawrence 66
Altamura 65
Moscow 65
The Dalles 63
Council Bluffs 54
Princeton 53
Hanoi 51
Kent 51
Shanghai 50
Helsinki 48
Boston 38
São Paulo 37
Melbourne 34
San Diego 31
Mumbai 30
Turku 30
Frankfurt am Main 29
Clifton 26
Medford 26
London 25
Jakarta 24
Naples 23
Tokyo 21
Chicago 20
Dallas 20
Orem 19
Brooklyn 18
San Francisco 17
Bengaluru 16
Stockholm 16
Toronto 15
Boardman 14
Chennai 14
Guangzhou 14
Montreal 14
Turin 14
Baghdad 13
Bologna 13
Brussels 13
Lappeenranta 13
Phoenix 13
Genoa 12
Shenzhen 12
West Jordan 11
Abidjan 10
Da Nang 10
Dong Ket 10
Haiphong 10
Pune 10
Abuja 9
Bari 9
Belo Horizonte 9
Brescia 9
Johannesburg 9
Salt Lake City 9
Amsterdam 8
Atlanta 8
Cascina 8
Falls Church 8
Miano 8
Padua 8
Poplar 8
Tashkent 8
Venice 8
Yubileyny 8
Denver 7
Elk Grove Village 7
Manchester 7
Nanjing 7
Ninh Bình 7
Norwalk 7
Totale 8.907
Salva come PNG Salva come JPEG
Nome #
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 296
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 282
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 265
Pros-IT CNR: an Italian prostate cancer monitoring project 247
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 247
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 243
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 237
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 231
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 224
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 219
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 218
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 218
Influence of age and subtype in outcome of operable liposarcoma 218
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 217
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 216
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 215
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 207
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 207
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 206
Methodological approach to create an atlas using a commercial auto-contouring software 206
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 201
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 199
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 196
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 193
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 193
Prognostic Impact of Post-Diagnosis Smoking Cessation among Bladder Cancer Patients: A Systematic Literature Review and Meta-Analysis 190
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 189
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 188
Thermal Ablation versus SBRT in liver tumours: pros and cons 188
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 186
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 186
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 185
Impact of COVID-19 on workload burden of a complex radiotherapy facility 183
Artificial Intelligence in radiotherapy: state of the art and future directions 182
Enhancing patient safety in radiotherapy: Implementation of a customized electronic checklist for radiation therapists 181
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 179
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 179
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 178
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 178
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 177
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 172
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 171
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 168
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 166
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 165
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 164
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 163
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 161
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 160
In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients 154
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 153
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 153
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 152
In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer 151
Prognostic impact of nodal relapse in definitive prostate-only irradiation 150
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 148
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients 145
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 145
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 144
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 144
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 142
Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature 142
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 139
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 139
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 138
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 138
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 137
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 131
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 129
The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents 129
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 118
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 112
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 92
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 85
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914) 61
null 57
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes 29
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 25
The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease 25
Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach 25
Totale 13.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 11 10 38 32 16 20 12 37 17 19 65 110
2022/20231.200 77 229 65 49 99 212 143 84 177 6 32 27
2023/2024681 23 52 71 32 37 99 38 178 9 35 73 34
2024/20254.179 121 350 215 636 1.140 512 68 279 231 147 185 295
2025/20265.256 583 659 525 406 593 172 651 245 326 349 225 522
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 13.636